ADMA (ADMA Biologics) E10: $-0.79 (As of Mar. 2026)


ADMA ADMA Biologics Inc ADMA
64 GF Score
Price $8.71
GF Value $17.93
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is ADMA Biologics E10?

ADMA Biologics ADMA +0.23% 64 E10 is $-0.79 as of Mar. 2026. GuruFocus rates ADMA with a GF Score™ of 64/100 and a GF Value™ of $17.93 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ADMA Biologics's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.79 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 19.80% per year. During the past 5 years, the average E10 Growth Rate was 13.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ADMA Biologics was 19.80% per year. The lowest was 3.00% per year. And the median was 10.30% per year.

As of today (2026-06-24), ADMA Biologics's current stock price is $8.705. ADMA Biologics's E10 for the quarter that ended in Mar. 2026 was $-0.79. ADMA Biologics's Shiller PE Ratio of today is .


ADMA Biologics  (NAS:ADMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ADMA Biologics E10 Related Terms


ADMA Biologics E10 Historical Data

* Premium members only.

The historical data trend for ADMA Biologics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADMA Biologics E10 Chart

ADMA Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.74 -1.67 -1.41 -1.12 -0.86

ADMA Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.08 -1.01 -0.94 -0.86 -0.79

ADMA vs ZYME, NRIX, IOVA: E10 Comparison

For the Biotechnology subindustry, ADMA Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADMA Biologics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADMA Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ADMA Biologics's Shiller PE Ratio falls into.


ADMA
64GF Score
ADMA Biologics Inc ADMA
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADMA Biologics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ADMA Biologics's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.19/330.2130*330.2130
=0.190

Current CPI (Mar. 2026) = 330.2130.

ADMA Biologics Quarterly Data

per share eps CPI Adj_EPS
201606 -0.500 241.018 -0.685
201609 -0.340 241.428 -0.465
201612 -0.350 241.432 -0.479
201703 -0.510 243.801 -0.691
201706 -0.550 244.955 -0.741
201709 -0.590 246.819 -0.789
201712 -0.286 246.524 -0.383
201803 -0.390 249.554 -0.516
201806 -0.350 251.989 -0.459
201809 -0.330 252.439 -0.432
201812 -0.390 251.233 -0.513
201903 -0.280 254.202 -0.364
201906 -0.250 256.143 -0.322
201909 -0.190 256.759 -0.244
201912 -0.180 256.974 -0.231
202003 -0.260 258.115 -0.333
202006 -0.230 257.797 -0.295
202009 -0.190 260.280 -0.241
202012 -0.200 260.474 -0.254
202103 -0.160 264.877 -0.199
202106 -0.150 271.696 -0.182
202109 -0.130 274.310 -0.156
202112 -0.090 278.802 -0.107
202203 -0.130 287.504 -0.149
202206 -0.070 296.311 -0.078
202209 -0.080 296.808 -0.089
202212 -0.060 296.797 -0.067
202303 -0.030 301.836 -0.033
202306 -0.030 305.109 -0.032
202309 0.010 307.789 0.011
202312 -0.080 306.746 -0.086
202403 0.080 312.332 0.085
202406 0.130 314.175 0.137
202409 0.150 315.301 0.157
202412 0.460 315.605 0.481
202503 0.110 319.799 0.114
202506 0.140 322.561 0.143
202509 0.150 324.800 0.152
202512 0.200 324.054 0.204
202603 0.190 330.213 0.190

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.79 mean?
ADMA Biologics (ADMA) has a E10 of $-0.79 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ADMA Biologics and its competitors.
Is ADMA Biologics' E10 too high?
ADMA Biologics' current E10 is $-0.79. Overall, ADMA Biologics has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ADMA Biologics' E10 compare to ZYME and NRIX?
ADMA Biologics' E10 of $-0.79 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ADMA Biologics and its competitors. ADMA Biologics's current E10 is $-0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADMA Biologics stock overvalued right now?
Based on GuruFocus' analysis, ADMA Biologics (ADMA) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.93, compared to a current price of $8.71 — trading 51.5% below its estimated fair value. The current E10 is $-0.79. ADMA Biologics' overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For ADMA Biologics (ADMA), the current E10 is $-0.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADMA Biologics (ADMA) Overvalued in 2026?

Based on GuruFocus' analysis, ADMA Biologics stock appears to be undervalued. The current stock price of $8.71 is trading 51.5% below its estimated GF Value™ of $17.93. GuruFocus considers ADMA Biologics to be Significantly Undervalued.

Key valuation signals for ADMA:

  • E10: $-0.79
  • GF Value™: $17.93 vs. price of $8.71 (51.5% below fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the ADMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADMA Biologics Business Description

Address 465 State Route 17, Ramsey, NJ, USA, 07446
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
64GF Score

Get the complete analysis for ADMA

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.71
Price
$17.93
GF Value